Chemistry:Ensaculin
From HandWiki
Short description: Chemical compound
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Pharmacokinetic data | |
| Elimination half-life | 13.7 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C26H32N2O5 |
| Molar mass | 452.543 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
  (what is this?) (verify) | |
Ensaculin (KA-672) is a drug from the coumarin family, which has been researched as a potential treatment for dementia. It acts on a number of receptor systems, being both a weak NMDA antagonist and a 5HT1A agonist.[1][2] Animal studies have shown promising nootropic effects,[3][4] although efficacy in humans has yet to be proven. It was well tolerated in human trials, with the main side effect being orthostatic hypotension (low blood pressure).[5]
See also
References
- ↑ "The putative cognitive enhancer KA-672.HCl is an uncompetitive voltage-dependent NMDA receptor antagonist". NeuroReport 9 (18): 4193–7. December 1998. doi:10.1097/00001756-199812210-00035. PMID 9926872.
- ↑ "The discriminative stimulus effects of KA 672, a putative cognitive enhancer: evidence for a 5-HT1A component". Pharmacology, Biochemistry, and Behavior 60 (3): 703–7. July 1998. doi:10.1016/S0091-3057(98)00043-4. PMID 9678654.
- ↑ "Ensaculin (KA-672 HCl): a multitransmitter approach to dementia treatment". CNS Drug Reviews 8 (2): 143–58. 2002. doi:10.1111/j.1527-3458.2002.tb00220.x. PMID 12177685.
- ↑ "Anseculin improves passive avoidance learning of aged mice". Pharmacological Research 47 (3): 225–33. March 2003. doi:10.1016/S1043-6618(02)00311-0. PMID 12591018.
- ↑ "KA 672-HCl, a neuronal activator against dementia: tolerability, safety, and preliminary pharmacokinetics after single and multiple oral doses in healthy male and female volunteers". Journal of Clinical Pharmacology 38 (4): 373–81. April 1998. doi:10.1002/j.1552-4604.1998.tb04438.x. PMID 9590466.
 |  |
